Biotech profile: Novogen
05 May, 2009 by Kate McDonaldNovogen has developed a technology platform based on synthetic isoflavones that promises compounds which can kill cancer cells without harming healthy cells.
Australian biotech market today 05.05.09
05 May, 2009 by Kate McDonaldCOH, CSL, RMD, Pharmaxis, Sonic Healthcare, Avexa, Cellestis
Pharmaxis progresses Bronchitol
05 May, 2009 by Kate McDonaldPositive data from Pharmaxis’ Phase III trial in cystic fibrosis
Profile: Implicit Biosciences
29 April, 2009 by Kate McDonaldBrisbane biotech Implicit Bioscience has developed a business model unusual in Australia: it aims to return money to investors.
Biotech profile: Hexima
28 April, 2009 by Kate McDonaldMelbourne agbiotech Hexima has been making waves with its fungal and insect-resistance technology and a tasty deal with DuPont.
Australian biotech market today 28.04.09
28 April, 2009 by Kate McDonaldBiota, CSL, Hexima, Alchemia, Mesoblast
Mesoblast fuses Phase II
28 April, 2009 by Kate McDonaldMesoblast approved for Phase II trail for cervical spine fusion
Prima applies for IND
28 April, 2009 by Kate McDonaldPrima BioMed applies for IND for CVac, raises cash
I am the walrus
24 April, 2009 by Kate McDonald“Walking seal” fossil sheds light on land-to-sea transition and pinniped evolution
Australian biotech market today 23.04.09
23 April, 2009 by Kate McDonaldBiota, Circadian, Clinuvel, Cochlear, Pharmaxis, Diversa
Thank you, Darling – UK spends on tech
23 April, 2009 by Kate McDonaldUK taxes rich, spends on tech investment fund
Australian biotech market today 22.04.09
22 April, 2009 by Kate McDonaldGenetic Technologies, Circadian, Bionomics, Ambri, Hexima, LCT, Pharmaxis, Cellestis, AIC
Bionomics targets throat cancer
22 April, 2009 by Kate McDonaldThroat cancer added to list of targets for VDA, Celera developing proteomics-based lung cancer diagnostic
Solid performance for biotech: PwC
21 April, 2009 by Kate McDonaldLatest PwC BioForum report has unexpected good news, but fundamentals are unchanged
Australian biotech market today 21.04.09
21 April, 2009 by Kate McDonaldNeuren, ChemGenex, Novogen, Biota, Alchemia, Impedimed, Sirtex
